Skip Nav Destination
Issues
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2024 2024, Vol. 102, No. 6
Clinical Study
Association between Lower Lobe Location and Early Recurrence for Non-Small Cell Lung Cancer
Subject Area:
Oncology
Oncology (2024) 102 (6): 441–446.
https://doi.org/10.1159/000533603
Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study)
Subject Area:
Oncology
Shogo Kobayashi; Hiroshi Wada; Daisuke Sakai; Hideo Baba; Masashi Kanai; Hirofumi Kamachi; Tadatoshi Takayama; Masaki Ueno; Masahiro Takahashi; Masayuki Sho; Kenichi Yoshimura; Etsuro Hatano; Hiroaki Nagano; Tatsuya Ioka; on behalf of Kansai Hepato-Biliary Oncology (KHBO) Group
Oncology (2024) 102 (6): 447–456.
https://doi.org/10.1159/000533669
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases
Subject Area:
Oncology
Kyosuke Nishio; Takuya Higashio; Kazumasa Komura; Wataru Fukuokaya; Takahiro Adachi; Yosuke Hirasawa; Takeshi Hashimoto; Atsuhiko Yoshizawa; Shuya Tsuchida; Takuya Matsuda; Takuya Tsujino; Kazuki Nishimura; Satoshi Tokushige; Keita Nakamori; Taizo Uchimoto; Shutaro Yamamoto; Kosuke Iwatani; Fumihiko Urabe; Keiichiro Mori; Takafumi Yanagisawa; Shunsuke Tsuduki; Kyoshi Takahara; Teruo Inamoto; Jun Miki; Takahiro Kimura; Yoshio Ohno; Ryoichi Shiroki; Haruhito Azuma
Oncology (2024) 102 (6): 457–464.
https://doi.org/10.1159/000534554
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study
Subject Area:
Oncology
Changwan Jeon; Su Hwan Kang; Sung-Bae Kim; Nam-Sun Paik; Ilkyun Lee; Seung Ki Kim; Eun Young Kim; Gil Soo Son; Young Bum Yoo; Kyung-Hee Lee; JeongSoo Shin; Sungil Ju; Harah Jang; Min Ho Park
Oncology (2024) 102 (6): 465–475.
https://doi.org/10.1159/000534626
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy
Subject Area:
Oncology
Takahito Sugase; Takashi Kanemura; Tomohira Takeoka; Norihiro Matsuura; Yasunori Masuike; Naoki Shinno; Hisashi Hara; Takeshi Omori; Masatoshi Kitakaze; Masahiko Kubo; Yosuke Mukai; Toshinori Sueda; Shinichiro Hasegawa; Hirofumi Akita; Junichi Nishimura; Hiroshi Wada; Masayoshi Yasui; Hiroshi Miyata
Oncology (2024) 102 (6): 484–493.
https://doi.org/10.1159/000535186
Immunohistochemical Expression of Insulin-Like Growth Factor-1 Receptor and Its Association with Clinicopathological Parameters in Hepatocellular Carcinoma
Subject Area:
Oncology
Maria Luiza Peloso Maia; Ronniel Morais Albuquerque; Serena Dafne do Carmo Silva; Cristiano Xavier Lima; Paulo Henrique Costa Diniz; Paula Vieira Teixeira Vidigal
Oncology (2024) 102 (6): 494–502.
https://doi.org/10.1159/000535332
Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations
Subject Area:
Oncology
Marie Mikuteit; Stefanie Zschäbitz; Michael Autenrieth; Wilko Weichert; Arndt Hartmann; Sandra Steffens; Franziska Erlmeier
Oncology (2024) 102 (6): 503–509.
https://doi.org/10.1159/000535473
The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis
Subject Area:
Oncology
Cho-Han Chiang; Yu-Cheng Chang; Yulin Haw; Jia Yi Tan; Cho-Hsien Chiang; Yuan Ping Hsia; Cho-Hung Chiang
Oncology (2024) 102 (6): 510–514.
https://doi.org/10.1159/000535737
Oncology and Informatics – Research Article
Co-Culture Device for in vitro High Throughput Analysis of Cancer-Associated Fibroblast and Cancer Cell Interactions
Subject Area:
Oncology
Oncology (2024) 102 (6): 515–524.
https://doi.org/10.1159/000533773
Research Article
Effects of Lobectomy versus Sub-Lobar Resection on the Survival in Adults with Stage IA Left Upper Lobe Non-Small Cell Lung Cancer: A Retrospective Cohort Study Based on the Surveillance, Epidemiology, and End Results Database
Subject Area:
Oncology
Oncology (2024) 102 (6): 525–532.
https://doi.org/10.1159/000534195
Association between Artificial Sweetener-Aspartame Consumption and Colorectal Cancer Risk: Evidence-Based Strategies
Subject Area:
Oncology
Oncology (2024) 102 (6): 533–543.
https://doi.org/10.1159/000534812
Erratum
Erratum - The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
Subject Area:
Oncology
Oncology (2024) 102 (6): 545–546.
https://doi.org/10.1159/000538018
Erratum - Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis
Subject Area:
Oncology
Oncology (2024) 102 (6): 547.
https://doi.org/10.1159/000538352
